ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Scrip's Five Must-Know Things - 22 July 2024"
Episode Synopsis
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track for blockbuster status; US uptake of Rezzdifra held up by payers; CNS drugs are surprisingly valuable; obesity rules large cap stocks; and Legend buyout rumors validate China biotech.
https://scrip.citeline.com/SC150621/Quick-Listen-Scrips-Five-MustKnow-Things
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
https://scrip.citeline.com/SC150621/Quick-Listen-Scrips-Five-MustKnow-Things
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
In God we trust